##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 48 Download : 45

##plugins.themes.academic_pro.article.main##

Abstract

Oxygen is required by the cells of most organisms to produce sufficient ATP for metabolic activity. Hypoxia, or oxygen deprivation, occurs in human tissues and cells due to a variety of conditions, including heart and lung diseases, anemia, and circulatory disorders. Depending on the severity, irreversible tissue and cell damage may occur

Keywords

Oxygen diseases circulatory cells

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Sayfutdinova Z.A. (2024). Modern biochemical methods used in the diagnosis of experimental toxic hepatitis. Texas Journal of Medical Science, 29, 88–93. https://doi.org/10.62480/tjms.2024.vol29.pp88-93
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Carmeliet P, Dor Y, Herbert J, et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature. 1998;394:485–490. [PubMed] [Google Scholar]
  2. Chapman-Smith A, Lutwyche JK, Whitelaw ML. Contribution of the Per/Arnt/Sim (PAS) domains to DNA binding by the basic helix-loop-helix PAS transcriptional regulators. J Biol Chem. 2004;279:5353–5362. [PubMed] [Google Scholar]
  3. Chen EY, Fujinaga M, Giaccia AJ. Hypoxic microenvironment within an embryo induces apoptosis and is essential for proper morphological development. Teratology. 1999;60:215–225. [PubMed] [Google Scholar]
  4. Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell. 2003;112:645–657. [PMC free article] [PubMed] [Google Scholar]
  5. Date T, Mochizuki S, Belanger AJ, et al. Expression of constitutively stable hybrid hypoxia-inducible factor-1α protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. Am J Physiol. 2005;288:C314–C320. [PubMed] [Google Scholar]
  6. Dery MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Bio. 2004;37:535–540. [PubMed] [Google Scholar]
  7. Donghoon Y, Pastore YD, Vladimir D, et al. HIF-1α-deficiency results in dysregulated EPO signaling and iron homeostasis in mouse development. JBC Papers in Press. 2006 [Google Scholar]
  8. Сайфутдинова З.А., Каримов Х.Я., Саидов А.Б. Механизмы нарушений при токсическом повреждении печени и пути их коррекции с помощью нового аминокислотного раствора на основе сукцината натрия и маннитола // Журнал теоретической и клинической медицины-2021. - №3. –Б. 7-11.
  9. Саидов А.Б., Курбонова З.Ч., Сайфутдинова З.А., Шомансурова Г.Е. Қон компонентларида биохимик кўрсаткичлар лаборатор ташхиси // Замонавий клиник лаборатор ташхиси долзарб муаммолари. – 2022. – №1. - Б. 158-159.
  10. Сайфутдинова З.А. Современные представления о гипоксии-индуцибельном факторе-1 (hif-1) – важном звене в патогенезе ишемических повреждений тканей // Вестник Ташкентской медицинской академии-2021. - №3. –Б. 33-36.
  11. Сайфутдинова З.А., Каримов Х.Я., Саидов А.Б. Патофизиологическое обоснование применения новой аминокислотной смеси при повреждении печени // Тиббиётда янги кун-2021. - №4. –Б. 93-96.
  12. Сайфутдинова З.А., Каримов Х.Я. Сравнительная оценка эффективности нового аминокислотного кровезаменителя при экспериментальном токсическом гепатите // Вестник Ташкентской медицинской академии-2021. - № Выпуск посвящается 100-летию ташкентской медицинской академии. –Б. 217-220.
  13. Сайфутдинова З.А., Каримов Х.Я., Саидов А.Б. Анализ эффективности применения новой аминокислотной смеси при гелиотриновом поражении печени по данным морфологических методов исследований // Медицинские новости- 2021. -№7· –Б. 57-59.
  14. Huang LE, Gu J, Schau M, Bunn HF. Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependant degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 1998;95:7987–7992. [PMC free article] [PubMed] [Google Scholar]
  15. Ivan M, Haberberger T, Gervasi DC, et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci USA. 2002;99:13459–13464. [PMC free article] [PubMed] [Google Scholar]
  16. Iver NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998;12:149–162. [PMC free article] [PubMed] [Google Scholar]
  17. Kido M, Du L, Sullivan CC, et al. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J Am Coll Cardiol. 2006;46:2116–2124. [PubMed] [Google Scholar]
  18. Krick S, Eul BG, Hanze J, Savai R, Grimminger F, Seeger W, Rose F. Role of hypoxia-inducible factor-1α in hypoxia induced apoptosis of primary alveolar epithelial type II cells. Am J Resp Cell Molec Bio. 2005;32:395–403. [PubMed] [Google Scholar]
  19. Laderoute KR, Amin K, Calaoagan JM, et al. 5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol Cell Biol. 2006;26:5336–5347. [PMC free article] [PubMed] [Google Scholar]
  20. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising cancer reagent. Pharmacotherapy. 2003;23:165–172. [PubMed] [Google Scholar]
  21. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science. 2002;295:858–861. [PubMed] [Google Scholar]
  22. Mole DR, Maxwell PH, Pugh CW, Ratcliffe PJ. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. IUBMB Life. 2001;52:43–47. [PubMed] [Google Scholar]
  23. Natarajan R, Salloum FN, Fisher BJ, Kukreja RC, Fowler AA. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res. 2006;98:133–140. [PubMed] [Google Scholar]
  24. Oda T, Hirota K, Nishi K, et al. Activation of hypoxia-inducible factor 1 during macrophage differentiation. Physiol Cell Physiol. 2006;291:C104–C113. [PubMed] [Google Scholar]
  25. Page EL, Robitaille GA, Pouyssegur J, Richard DE. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J Biol Chem. 2002;277:48403–48409. [PubMed] [Google Scholar]
  26. Pajusola K, Kunnapuu J, Vuorikoski S, et al. Stabilized HIF-1α is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J. 2005;19:1365–1367. [PubMed] [Google Scholar]
  27. Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006;3:150–151. [PubMed] [Google Scholar]
  28. Rebar EJ. Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease. Expert Opin Investig Drugs. 2004;13:829–839. [PubMed] [Google Scholar]
  29. Richard DE, Berra E, Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J Biol Chem. 2000;275:26765–26771. [PubMed] [Google Scholar]
  30. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol. 2000;88:1474–1480. [PubMed] [Google Scholar]
  31. Shi YH, Fang WG. Hypoxia-inducible factor-1 in tumour angiogenesis. World J Gastroenterol. 2004;10:1082–1087. [PMC free article] [PubMed] [Google Scholar]
  32. Trentin D, Hall H, Wechsler S, Hubbell JA. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1 alpha variant for local induction of angiogenesis. Proc Natl Acad Sci USA. 2006;103:2506–2511. [PMC free article] [PubMed] [Google Scholar]
  33. Vaupel P. The Role of Hypoxia-Induced Factors in Tumor Progression. Oncologist. 2004;9:10–17. [PubMed] [Google Scholar]
  34. Vincent KA, Shyu KG, Luo Y, et al. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1α/VP16 Hybrid Transcription Factor. Circulation. 2000;102:2255–2261. [PubMed] [Google Scholar]
  35. Wang GL, Jiang B, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92:5510–5514. [PMC free article] [PubMed] [Google Scholar]
  36. Yang J, Zhang L, Erbel PJ, Gardner KH, Ding K, Garcia JA, Bruick RK. Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor. J Biol Chem. 2005;280:36047–36054. [PubMed] [Google Scholar]
  37. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL. Expression of hypoxia-inducible factor 1α in brain tumors: association with angiogenesis, invasion, and progression. Cancer. 2000;88:2606–2618. [PubMed] [Google Scholar]
  38. Zhang H, Gao P, Fukuda R, et al. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell. 2007;11:407–420. [PubMed] [Google Scholar]